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Background: Delayed diagnosis and treatment of tuberculosis increase both the severity of the disease and the
duration of infectivity. A number of studies have addressed the issue of health system delays in the treatment of
tuberculosis, but mostly in countries with a high or low incidence of the disease. Our understanding of delay is
quite limited in settings with an intermediate burden of tuberculosis. We explore the duration and factors
associated with delays in the Croatian health system which has free health care and a sufficient network of health
services providing tuberculosis diagnosis and care.
Methods: A total of 241 consecutive adults with culture-confirmed pulmonary tuberculosis were interviewed in
seven randomly selected Croatian counties and their medical records were evaluated. A health system delay was
defined as the number of days from the first consultation with a physician to the initiation of anti-tuberculosis
treatment. A long delay was defined as a period exceeding the median delay, while an extreme delay was
considered to be above the 75th percentile delay.
Results: The median health system delay was 15 days while the 75th percentile was 42 days (the 5th and 95th
percentile being 1 and 105 days respectively). Almost 30% of tuberculosis patients remained undiagnosed for more
than 30 days after the initial health care visit. Female patients (p = 0.005), patients with a negative sputum smear
(p = 0.002) and patients having symptoms other than the usual ones (0.027) were found to be in significant
correlation with a long delay. In a multivariate model, a long delay remained associated with the same variables
(p = 0.008, p = 0.003, and p = 0.037, respectively).
A significant association was demonstrated between both the female gender (p = 0.042) and a negative sputum
smear (p < 0.001) and extreme delay, while only a negative sputum smear (p < 0.001) remained significant in the
multivariate analysis.
Conclusions: Our findings suggest that some groups of tuberculosis patients experienced a health system delay. In
such a setting where tuberculosis incidence is decreasing, which leads to a lack of physician experience and
expertise, training in tuberculosis is required. Such measure may be useful in reducing the number of missed
opportunities for tuberculosis diagnosis.
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Prompt diagnosis and early treatment of tuberculosis
(TB) constitute the most effective intervention in con-
trolling and reducing the transmission of Mycobacterium
tuberculosis. It is generally assumed that a delay in the
diagnosis and treatment of TB increases the severity of
the disease and the risk of death and leads to newly
infected persons who can become reservoirs of new tu-
berculosis cases at a future point in time [1]. The timely
and accurate diagnosis and treatment of TB are there-
fore essential. TB diagnosis can be delayed when patients
postpone seeking care after the onset of symptoms or
when more time is required for health providers to diag-
nose and treat patients. Since the same variable can
move in opposite directions, being a risk factor for one
delay and a protective factor for another, it is important
to consider the two types of delay separately [2,3].
Health system delays show the level of TB knowledge
and the efficiency of a country’s National Tuberculosis
Control Programme (NTP). Thus, the importance and
significance of this particular issue is important for the
evaluation and planning of interventions through a par-
ticular NTP [1,4], drafted in line with the sixth compo-
nent of the Stop TB Strategy [5].
A number of studies have addressed the issue of health
system delay in the treatment of tuberculosis, though
mostly in high- or low-incidence countries [2,3]. This
problem, however, is found to be important in both de-
veloped and developing countries. Still, there is no con-
sensus on the acceptable duration of delay. Our
understanding of the extent and causative factors of
health system delay in medium incidence countries is
quite limited. In settings where TB is not frequent, it is
usually difficult to achieve a high degree of suspicion
and to perform immediate diagnostic procedures for tu-
berculosis. One of these settings is Croatia, with a TB in-
cidence rate of 19 / 100 000 in 2009 and showing a
decreasing trend [6,7].
The potential loss of time in the diagnosis and treat-
ment of TB patients, resulting from health system de-
lays, has never been explored in this country.
A study investigating both types of delay was
conducted on the same participants. The results of pa-
tient delay have already been published [8]. Identifying
the duration and the factors related to the health system
delay was the objective of this part of the study.
Methods
Setting
Croatian TB services are integrated in the mainstream
national health system and rely on general practitioners/
family medicine physicians guiding TB patients through
the entire procedure and course of treatment. The avail-
ability and network of health services providing TB careand diagnosis are believed to be sufficient in Croatia
[6,9,10], as revealed in a study on patient delay where
the long distance to a health facility was among the very
few reasons (1.3% of participants) for delay [8]. A devel-
oped network of 14 TB laboratories meets international
requirements and each laboratory performs microscopy
and culture procedures. The laboratory notification sys-
tem reports smear-positive results within 24 hours and
positive culture results immediately upon cultivation
[11]. The Croatian health system allows for as many
medical visits as required and for as many tests as the
GP finds necessary, free of charge to the patient, in the
case of many infectious diseases, including tuberculosis.
TB treatment is also free of charge, with the institutional
procurement of drugs and an uninterrupted supply of
first-line drugs [11]. This explains the common reasons
for the health system delay being identified elsewhere
[12-14]. Causative laboratory delays and distances to the
health provider were, however, not explored in the
present study.
Design
This cross-sectional study was performed in seven
Croatian counties between April and December 2006.
The idea was to include more than 50% of the Croatian
population and more than 50% of TB patients registered
in the preceding year. This study was started in eight
randomly selected counties out of 21, covering 60.8% of
the Croatian population and 53.6% of all registered TB
patients in the preceding year. In the course of the
study, one county was later excluded along with all
interviewees because the investigator was moved to an-
other non-participating county. Therefore, seven coun-
ties with 48% of all TB patients and 53.9% of the
Croatian population were finally covered. A team of epi-
demiologists who had been working in TB control
interviewed the consecutive TB patients in hospitals or
in their homes, and reviewed their medical records
within one month of the diagnosis of TB. The question-
naire was pre-tested for clarity and consistency, and
modified accordingly. Data on demographic, socioeco-
nomic, a high-risk life style and diagnostic factors were
collected. Smoking status was classified as non-smoker,
ex-smoker (previously smoking at any time in their life-
time) and current smoker. Data on alcohol consumption
were collected during the previous 12 months and the
subjects were classified as non-consumer (no alcohol
consumption in the last 12 months), ex-consumer (alco-
hol had been consumed during the last 12 months but
the patient had stopped consuming by the time of the
interview) and current consumer. Drug use was defined
as use of any drug in the lifetime. Other symptoms were
all reported symptoms apart from the classic symptoms
(a cough with or without blood, fever, weight loss,
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mass index (kg/m2) on the date of the interview was
classified as underweight <18.50, normal range 18.50-
24.99, and overweight ≥25.00.
The study was approved by the Ethics Committee of
Teaching Public Health Institute of Split and Dalmatia
County and all patients provided informed written
consent.
Inclusion and exclusion criteria
Cases that were detected through passive case-finding
were defined as all adults (aged 15 years and older) with
culture-confirmed pulmonary tuberculosis. TB patients
who were identified during contact tracing, patients who
had no symptoms before the diagnosis (e.g. identified
during preoperative procedures), and patients with a
previous history of TB treatment were excluded. The
said patients had already had TB data recorded in their
medical records and it was reasonable to assume that
their physicians would have had a higher degree of sus-
picion when TB symptoms presented again. Such doc-
tors would have thus been more alert and would have
acted accordingly.
Definitions
‘Health system delay’ was defined as the number of days
from the first consultation with a physician (either pri-
mary care or other) to the initiation of anti-TB treat-
ment. In the absence of a standard definition, ‘long
health system delay’ was defined as a period exceeding
the median delay observed in the study population,
while ‘extreme delay’ was defined as a period exceeding
the 75th percentile delay. We did not separate diagnostic
delay from treatment delay since it is standard practice
in Croatia to start anti-TB therapy immediately following
diagnosis.
Data analysis
It was estimated that 160 participants (80 per group)
should be included in this study to achieve an 80%
power to detect an odds ratio of 2.5 with an alpha of
0.05. The median and 75th percentile delays were calcu-
lated for all patients and all variables. We compared the
distribution of delay ≤median (or the 75th percentile)
with delay > median (or the 75th percentile) by per-
forming the Pearson Chi-squared test for all variables.
The association of long and extreme delays with differ-
ent variables was estimated using the crude odds ratios
(OR) and 95% confidence intervals (CI). To identify fac-
tors independently associated with long and extreme
health system delays, a multivariate logistic regression
analysis was performed. All variables significant at a uni-
variate level, as well as age groups, were included in
the initial logistic regression model. The backwardelimination procedure was used to identify the variables
remaining in the final model and in the model-building
strategies proposed by Hosmer and Lemeshow [15]. All
analyses were conducted using Statistica 8.0 computer
software (StatSoft Inc., Tulsa, USA). The level of statis-
tical significance was defined as p < 0.05.
Results
A total of 300 subjects were potentially eligible for this
study. Among them, 41 patients had no clearly defined
symptom onset or no symptoms before the diagnosis, 5
were identified during contact tracing, and 11 patients
had a previous history of TB treatment. A total of 243
subjects were found to be eligible, two of whom refused
to participate. A total of 241 participants were inter-
viewed, 134 (56%) males and 107 (44%) females. The
median health system delay was 15 days while the 75th
percentile was 42 days (the 5th and 95th percentile being
1 and 105 days respectively).
Within 10 days of their first visit to a health care facil-
ity, 99 (40.9%) cases were diagnosed, 29 (12%) within 11-
20 days, 42 (17.4%) in the fourth week, while 71 (29.3%)
remained undiagnosed for more than 30 days after the
initial health care visit.
Descriptive information for the statistically significant
and other epidemiologically relevant variables, such as
demographic, socioeconomic and high-risk life style fac-
tors (Table 1), as well as diagnostic factors (Table 2),
were presented. The symptoms were reported in var-
ious combinations, with a cough (73%) being the most
frequently noted, followed by fatigue (65%) and weight
loss (57%).
When using the median as a cut-off to define long
delay, female patients (p = 0.005, OR = 2.11, 95% CI
1.256-3.531), negative sputum smears (p = 0.002, OR =
2.42, 95% 1.381-4.239) and any other symptoms apart
from those presented in the results (cough, cough with
blood, fever, weight loss, fatigue, night sweats and short-
ness of breath) (p = 0.027, OR = 2.57, 95% CI 1.113-
5.947) were found to be statistically significant. Other
symptoms were independently associated with delay,
with or without classic symptoms. Variables associated
with long delay in the multivariate analysis were the fe-
male gender (p = 0.008, aOR = 2.06, 95% CI 1.213-3.517)
and a negative sputum smear (p = 0.003, aOR = 2.38,
95% CI 1.341-4.236) with other symptoms (p = 0.037,
aOR = 2.50, 95% CI 1.055-5.940) (Table 3).
When using the 75th percentile to define extreme
delay, the female gender (p = 0.042, OR = 1.85, 95% CI
1.024-3.352) and a negative sputum smear (p < 0.001,
OR = 3.15, 95% CI 1.709-5.805) were both significant,
while only a negative sputum smear (p < 0.001, OR =
3.11, 95% CI 1.680-5.770) remained significant in the
multivariate analysis (Table 4).
Table 1 Health system delay by demographic and socioeconomic factors and a high-risk life style
Variable Number Median(days) No (%) of participants
with long delaya
No (%) of participants
with extreme delayb
Gender Total 241
Male 134 15 53 (39.6) 26 (19.4)
Female 107 28 62 (57.6) c 33 (30.8) d
Age groups Total 241
15-34 49 18 25 (51) 10 (20.4)
35-64 131 15 58 (44.3) 32 (24.4)
65+ 61 21 32 (52.5) 17 (27.9)
Place of birth Total 241
Croatia 184 15 87 (47.3) 42 (22.8)
Foreign born 57 15 28 (49.1) 17 (29.8)
Level of education Total 241
No schooling or only elementary school 116 21 61 (52.6) 33 (28.4)
Secondary school 102 15 44 (43.1) 20 (19.6)
Higher education 23 15 10 (43.5) 6 (26.1)
Household contact Total 241
Yes 47 8 18 (38.3) 8 (17.0)
No 194 16.5 97 (50.0) 51 (26.3)
Contact outside the household Total 241
Yes 84 21 43 (51.2) 22 (26.2)
No 157 15 72 (45.9) 37 (23.6)
Smoker Total 240
Non-smoker 76 21 43 (56.6) 22 (28.9)
Ex-smoker 80 15 36 (45.0) 20 (25.0)
Current smoker 84 15 36 (42.9) 17 (20.2)
Alcohol consumption Total 241
Non-consumer 104 21 55 (52.9) 30 (28.8)
Ex-consumer 28 15 12 (42.9) 6 (21.4)
Current consumer 109 15 48 (44.0) 23 (21.1)
Ever used drugs Total 241
Yes 13 30 9 (69.2) 5 (38.5)
No 228 15 106 (46.5) 54 (23.7)
a exceeding the median overall delay (15 days).
b exceeding the75th percentile overall delay (42 days).
c significance levels of p < 0.05 for univariate logistic regression using the median (15 days) as a cut-off.
d significance levels of p < 0.05 for univariate logistic regression using 75th percentile (42 days) as a cut-off.
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The present study is one of the few studies of tuberculosis
delay performed in countries with an intermediate burden
of TB and the first one exploring health system delays in
Croatia. We found that the median health system delay was
15 days. Numerous studies conducted elsewhere report
longer delays [2,12,16-22], although a few studies show
shorter delays [13,23-25].
Among demographic factors, only the female gender was
found to be significantly associated with both a long andextreme delay. This finding was also reported in other
countries [18,22,26-28], usually without pro- per explan-
ation. In some of these countries (Uganda, Bangladesh)
[22,26], cultural factors which might not have been relevant
for Croatian females were likely to be involved. In our
study, TB was clearly suspected and investigated more read-
ily among men, although women did not seek care any later
than men, as had previously been thought [8]. Therefore,
this interesting finding warrants further investigation. Al-
though it cannot be explained why women experienced
Table 2 Health system delay by diagnostic factor
Variable Number Median (days) No (%) of participants with long delaya No (%) of participants with extreme delayb
Previous hospitalisation Total 241
Yes 146 15 69 (47.3) 41 (28.1)
No 95 15 46 (48.4) 18 (18.9)
Comorbidity Total 241
Yes 101 18 51 (50.5) 28 (27.7)
No 140 15 64 (45.7) 31 (22.1)
Mantoux test results Total 241
Positive 222 15 107 (48.2) 4 (21.1)
Negative 19 15 8 (42.1) 55 (24.8)
Cavity on chest radiography Total 241
Yes 64 15 29 (45.3) 13 (20.3)
No 177 15 86 (48.6) 46 (26.0)
Specimen Total 241
Sputum 198 15 91 (46.0) 46 (23.2)
Other 43 24 24 (55.8) 13 (30.2)
Sputum smear-positive Total 241
Yes 166 15 68 (41.0) 29 (17.5)
No 75 30 47 (62.7) c 30 (40.0) d
Cough Total 241
Yes 176 15 84 (47.7) 40 (22.7)
No 65 15 31 (47.7) 19 (29.2)
Cough with blood Total 241
Yes 42 7 18 (42.9) 9 (21.4)
No 199 15 97 (48.7) 50 (25.1)
Fever Total 241
Yes 115 15 49 (42.6) 24 (20.9)
No 126 21 66 (52.4) 35 (27.8)
Weight loss Total 241
Yes 138 15 65 (47.1) 28 (20.3)
No 103 15 50 (48.5) 31(30.1)
Fatigue Total 241
Yes 156 15 71 (45.5) 34 (21.8)
No 85 21 44 (51.8) 25 (29.4)
Night sweats Total 241
Yes 112 15 46 (41.1) 21 (18.8)
No 129 28 69 (53.5) 38 (29.5)
Shortness of breath Total 241
Yes 73 15 31 (42.5) 18 (24.7)
No 168 16.5 84 (50.0) 41 (24.4)
Other symptoms Total 241
Yes 28 30 19 (67.9) c 7 (25.0)
No 213 15 96 (45.1) 52 (24.4)
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Table 2 Health system delay by diagnostic factor (Continued)
Body mass index e Total 237
Underweight 31 15 15 (48.4) 6 (19.4)
Normal 156 15 75 (48.1) 44 (28.2)
Overweight 50 15 24 (48.0) 9 (18.0)
a exceeding the median overall delay (15 days).
b exceeding the 75th percentile overall delay (42 days).
c significance levels of p < 0.05 for univariate logistic regression using the median (15 days) as a cut-off.
d significance levels of p < 0.05 for univariate logistic regression using the 75th percentile (42 days) as a cut-off.
e on the date of the interview.
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toms suggestive of TB should receive more attention after
seeking care.
The symptoms most frequently reported by patients
were a cough, fatigue and weight loss. Unexpectedly,
median delays were the same or similar both in the case
of having one of the symptoms or having none. In
addition, the presence of other symptoms was signifi-
cantly associated with a long delay. Symptoms, either
usual or not, are obviously not thought to be alarming
and/or TB-related.
One of the challenges of diagnosing TB in primary
care is to distinguish the symptoms of TB from those of
other common respiratory diseases especially common
in settings where community-acquired pneumonia and
other lung diseases are more frequent than TB [29].
However, physicians have to be aware that a certain
number of patients seeking medical assistance with
symptoms of respiratory tract infections may have TB. It
has been estimated that, on average, each generalTable 3 Logistic regression a analysis of a long health system
Univariate analysis
Variable p value OR (95%
Gender
Male 1
Female 0.005 2.11 (1.256
Age groups
15-34 1
35-64 0.420 0.76 (0.395
65+ 0.881 1.06 (0.499
Sputum smear
Positive 1
Negative 0.002 2.42 (1.381
Other symptoms
No 1
Yes 0.027 2.57 (1.113
a variables significant in the univariate logistic regression and age groups were incl
at p < 0.05.
b a long delay was considered to be above the median delay (15 days).
OR = Odds Ratio, CI = Confidence Interval.practitioner/family practice physician in Croatia has one
TB patient every two years [30]. Under these circum-
stances, it is easy to neglect many important issues in
TB management and control, resulting from a lack of
experience and expertise which had previously been
found to be associated with health system delays [31].
There was also a significant association between the
sputum-smear status and health system delay among pa-
tients with negative smears who had double the median,
as recently reported [27,32,33]. Smear-negative TB was
obviously more difficult to diagnose and may have re-
quired an assessment of the response to antibiotic treat-
ment, as well as chest radiography. These findings also
indicate the urgent need for a more robust diagnostic
test for diagnosing smear-negative cases in a timely
manner.
The findings of this study need to be interpreted in
the light of certain limitations. There may be a recall
bias with reference to the symptoms and the timeliness
of the health providers consulted. However, thedelay b
Multivariate analysis
CI) p value OR (95% CI)
1
-3.531) 0.008 2.06 (1.213-3.517)
1
-1.472) 0.96 0.98 (0.483-1.991)
-2.248) 0.811 1.10 (0.499-2.432)
1
-4.239) 0.003 2.38 (1.341-4.236)
1
-5.947) 0.037 2.50 (1.055-5.940)
uded in the multivariate logistic regression. Statistical significance was taken
Table 4 Logistic regression a analysis of an extreme
health system delay b
Univariate analysis Multivariate analysis
Variable p value OR (95% CI) p value OR (95% CI)
Gender
Male 1 1
Female 0.042 1.85 (1.024-3.352) 0.056 1.81 (0.986-3.344)
Age groups
15-34 1 1
35-64 0.571 1.26 (0.566-2.808) 0.261 1.63 (0.695-3.825)
65+ 0.368 1.51 (0.617-3.677) 0.461 1.42 (0.561-3.579)
Sputum smear
Positive 1 1
Negative <0.001 3.15 (1.709-5.805) <0.001 3.11 (1.680-5.770)
a variables significant in the univariate logistic regression and age groups were
included in the multivariate logistic regression. Statistical significance was
taken at p < 0.05.
b an extreme delay was considered to be above the 75th percentile
delay (42 days).
OR = Odds Ratio, CI = Confidence Interval.
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within one month after the TB diagnosis was made.
Moreover, interviewers had received special training in
two-day courses for proper data collection and control
through as many sources as possible. This approach is
believed to have minimised the bias. Another limitation
of this study was the lack of data on the first point of
contact with health professionals consulted for TB
symptoms. However, the Croatian health care system is
geared towards general practitioners/family practice phy-
sicians providing health care irrespective of socioeco-
nomic class. If necessary, patients are referred to a
specialist and TB drugs are available on prescription,
and only on prescription. The few exceptions to this rule
(emergency care, private doctor visit) are not likely to
have significantly influenced our results.
The strength of this study lies in the fact that it was
purpose designed. Secondly, this study covered almost
50% of all Croatian TB cases during the preceding year
and more than 50% of the overall Croatian population in
randomly selected counties. The dual TB notification
system (physician and laboratory notification) had been
successfully implemented since 1998 and so it can confi-
dently be assumed that all confirmed cases were in-
cluded in this study. Moreover, a larger sample size or
more participating counties might have caused an
under- or overestimation of delay.
Conclusions
Despite free health care being universally available in
Croatia and notwithstanding the ready availability of
health services, it is of great concern that almost 20% of
the patients under study remained undiagnosed in thefourth week after the initial health care visit, while one
month later, a high proportion of the participants
(29.3%) were still a source of infection within the com-
munity. Our findings appear to indicate some groups of
TB patients having experienced a health system delay
mainly due to a lack of suspicion. Although the health
system delay in this study was found to be shorter than
in many other countries, we believe that it could have
been even shorter or avoided altogether had appropriate
TB investigation been conducted earlier.Policy implications
From a public health point of view, it is imperative that
physicians be better trained in TB, especially in settings
where TB incidence is decreasing continuously. Em-
phasis should be placed on general practitioners/family
medicine physicians, since they are the pillar of the
health system and since most patients first go to them
for treatment. These measures may be useful in reducing
the number of missed opportunities for diagnosis and
should form part of an approach to eliminate TB in
countries with an intermediate tuberculosis burden.Competing interests
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